False Claims Act - G2 Intelligence

Special Report: The 2024 Lab Enforcement Landscape

Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing

Start a Free Trial for immediate access to this article

Already a member? Log in here

COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action

Start a Free Trial for immediate access to this article

Already a member? Log in here

Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing

Start a Free Trial for immediate access to this article

Already a member? Log in here

Examining DOJ and OIG investigations of labs and their owners: Recent cases show continued focus on the usual enforcement targets.

Start a Free Trial for immediate access to this article

Already a member? Log in here

How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation

Start a Free Trial for immediate access to this article

Already a member? Log in here